Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia?
Not Applicable
Recruiting
- Conditions
- SeromaBilateral Prophylactic MastectomyBRCA1/2 MutationPectoral Fascia
- Interventions
- Procedure: Fascia pectoralis preservation
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT05391763
- Locations
- 🇳🇱
Erasmus Medical Center, Rotterdam, Netherlands
Concomitant Intraperitoneal and Systemic Chemotherapy in Patients with Extensive Peritoneal Carcinomatosis of Gastric Origin
Phase 1
Completed
- Conditions
- Peritoneal MetastasesGastric Cancer
- Interventions
- Drug: CAPOX
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05379790
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Zuid-Holland, Netherlands
🇳🇱Catharina Hospital, Eindhoven, Netherlands
Coronary Physiology Peri-Transcatheter Left-sided Valvular Interventions
Not Applicable
- Conditions
- Aortic Valve StenosisMitral RegurgitationCoronary Artery DiseaseFractional Flow Reserve
- Interventions
- Diagnostic Test: Coronary Physiology assessment
- First Posted Date
- 2022-05-16
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT05374733
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer
Not Applicable
Active, not recruiting
- Conditions
- Prostate Cancer
- Interventions
- Radiation: Adaptive radiotherapy according to UPRATE protocol
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT05361902
- Locations
- 🇳🇱
Erasmus Medical Centre, Rotterdam, Zuid-Holland, Netherlands
Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum
Phase 3
Not yet recruiting
- Conditions
- Pyoderma Gangrenosum
- Interventions
- Other: Control group
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05343754
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Netherlands
NRP vs DHOPE vs COR-NMP in ECD-DCD Donation
Recruiting
- Conditions
- Liver TransplantOrgan PerfusionComplication of Surgical Procedure
- Interventions
- Procedure: NRPProcedure: DHOPEProcedure: COR-NMP
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT05327478
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Zuid-Holland, Netherlands
dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT05304208
- Locations
- 🇳🇱
Erasmus MC, Rotterdam, Zuid Holland, Netherlands
The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia
- Conditions
- Antibiotic Resistant InfectionCOVID-19
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 1110
- Registration Number
- NCT05293483
- Locations
- 🇮🇩
dr. Saiful Anwar hospital, Malang, East Java, Indonesia
🇮🇩Ngudi Waluyo hospital, Blitar, East Java, Indonesia
Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
- Conditions
- Pseudomonas AeruginosaNosocomial InfectionColonization, Asymptomatic
- First Posted Date
- 2022-03-16
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 3000
- Registration Number
- NCT05282082
- Locations
- 🇮🇩
Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
🇳🇱Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands
🇮🇹Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)
- Conditions
- Breast Carcinoma in SituBreast Cancer FemaleBreast FibrosisBreast NeoplasmsBreast CarcinomaBreast Cancer
- Interventions
- Other: no intervention
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 750
- Registration Number
- NCT05263362
- Locations
- 🇳🇱
Maasstad hospital, Rotterdam, Netherlands
🇳🇱Franciscus Gasthuis & Vlietland, Schiedam, Netherlands
🇳🇱Erasmus Medical Center, Rotterdam, Netherlands
© Copyright 2025. All Rights Reserved by MedPath